The device was received for evaluation and successfully passed the prime and alarms test confirming proper functionality of the device and sensors.Available log files were retrieved and analyzed which showed device performance was without incident and was unremarkable.A review of the device history record confirmed the product was released meeting all product design specifications and quality criteria.All information supports the device was functioning as designed and intended with no malfunction.The nxstage system one user guide states a trained and qualified person must respond promptly and appropriately to all alarms and harmful conditions during treatment.The nxstage system one user guide supplement for solo home hemodialysis outlines risks, warnings, and requirements for the solo home hemodialysis patient.(b)(4).
|
A report was received on (b)(6) 2021 from the home therapy nurse (htn) of a (b)(6) male patient with a medical history of end stage renal disease approved for performing solo home hemodialysis therapy, stating the patient expired during a hemodialysis session on (b)(6) 2021.Although requested, additional information has not been provided.
|